Tofacitinib enhances IGF1 via inhibiting STAT6 transcriptionally activated-miR-425-5p to ameliorate inflammation in RA-FLS.

MLA

Liu, Yingjie, et al. “Tofacitinib Enhances IGF1 via Inhibiting STAT6 Transcriptionally Activated-MiR-425-5p to Ameliorate Inflammation in RA-FLS.” Molecular and Cellular Biochemistry, vol. 477, no. 10, Oct. 2022, pp. 2335–44. EBSCOhost, https://doi.org/10.1007/s11010-022-04444-x.

APA

Liu, Y., Peng, J., Xiong, X., Cheng, L., & Cheng, X. (2022). Tofacitinib enhances IGF1 via inhibiting STAT6 transcriptionally activated-miR-425-5p to ameliorate inflammation in RA-FLS. Molecular and Cellular Biochemistry, 477(10), 2335–2344. https://doi.org/10.1007/s11010-022-04444-x

Chicago

Liu, Yingjie, Jun Peng, Xiaochuan Xiong, Liang Cheng, and Xiaobing Cheng. 2022. “Tofacitinib Enhances IGF1 via Inhibiting STAT6 Transcriptionally Activated-MiR-425-5p to Ameliorate Inflammation in RA-FLS.” Molecular and Cellular Biochemistry 477 (10): 2335–44. doi:10.1007/s11010-022-04444-x.